Search

Background: Hesitancy about vaccination during pregnancy posed challenges to SARS-CoV-2 vaccination efforts. We aimed to examine rates of SARS-CoV-2 vaccination among Ontario residents who gave birth in early 2022, and to compare rates of SARS-CoV-2 vaccine uptake with rates of tetanus, diphtheria, and pertussis (Tdap) and influenza vaccination during pregnancy in 2019, 2021, and 2022. Methods: We conducted a population-based retrospective cohort study to describe vaccination rates among pregnant and comparable nonpregnant populations in Ontario using linked administrative data. Provincially insured females who had a live, in-hospital birth from Jan. 1 to Mar. 31 in 2019, 2021, or 2022 were our primary cohort. Using log-binomial regression, we tested associations between SARS-CoV-2 (2022) and Tdap and influenza (2019, 2021, 2022) vaccination status, with birth group and covariates. We compared SARS-CoV-2 vaccination status with the status of a matched cohort of nonpregnant females and conducted subgroup analyses by age and prenatal clinician type. Results: Among birthing people, 78.7% received their first SARS-CoV-2 vaccine dose and 74.2% received a second dose. The rate was significantly higher among nonpregnant comparators (dose 1: relative risk [RR] 0.94, 95% confidence interval [CI] 0.93-0.94; dose 2: RR 0.91, 95% CI 0.90-0.91). However, the rate of SARS-CoV-2 vaccination uptake among birthing people was higher than uptake of Tdap or influenza vaccination. Tetanus, diphtheria, and pertussis vaccination increased over time from 22.2% in 2019 to 32.6% in 2022, and influenza vaccination rose to 35.3% in 2021 but returned to prepandemic levels in 2022 (27.7%). Vaccination rates were lower among pregnant people who were young, multiparous, or residents of rural or economically deprived areas for all 3 vaccines. Interpretation: Rates of SARS-CoV-2 vaccination were lower among pregnant people than among nonpregnant comparators but were higher than rates of routinely recommended Tdap and influenza vaccinations. Pandemic urgency may have overcome a great deal of hesitancy about vaccinating against SARS-CoV-2 during pregnancy in 2022, but uptake of routinely recommended vaccines in pregnancy remains a challenge. Trial registration: Clinicaltrials.gov, no. NCT05663762., Although pregnancy is associated with a higher risk of severe COVID-19, (1-8) pregnant people were not included in premarket clinical trials of SARS-CoV-2 vaccines. (9-12) On the basis of international [...]

THE human brain goes through significant changes during pregnancy with few regions untouched, according to the first ever map of this over the course of gestation and beyond. Some areas [...]

2024 JUL 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Cardiovascular Diseases and Conditions - Aortic Dissection have [...]

Our easy-to-read fact sheets provide clinicians with reliable information to share with patients and their caregivers. Respiratory syncytial virus (RSV) is a seasonal lower respiratory tract infection (LRTI) responsible for [...]

2024 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Liver Diseases and Conditions - Liver Fibrosis are discussed […]

In developing countries such as Nigeria, anaemia in pregnancy is thought to be one of the most common complications of pregnancy accounting for a significant level of maternal morbidity and mortality. The aim of this study was to determine the prevalence of anaemia in pregnancy among women attending the booking Antenatal Clinic (ANC) in Benue State University Teaching Hospital (BSUTH), North-Central, Nigeria. A cross-sectional descriptive study was conducted from May 2019 to January, 2020 on 299 women. A structured interviewer administered questionnaire was used to obtain socio-demographic, clinical, and nutritional information from pregnant women attending the clinic who consented to participate in the study. Haematocrit levels were stratified according to the World Health Organisation's (WHO) classification as follows: 0.05). However, parity, clinical features such as fever, and practices like use of haematinics and non-consumption of meat, poultry and fish were significantly related to anaemia (P < 0.05). The pregnant women who did not take haematinics were 5.8 times likely to develop anaemia (OR=5.8, 95%CI [2.3, 14.5]) while pregnant women who did not eat meat, poultry or fish were 9 times more likely to become anaemic than pregnant women who ate (OR=9.0, 95%CI [1.0, 79.5]). The prevalence of anaemia in pregnancy is high among women attending booking antenatal clinic at BSUTH, North-Central, Nigeria, and requires specific intervention that address the identified risk factors. (Afr J Reprod Health 2022; 26[12s]: 161-168). Keywords: Anaemia, antenatal clinic, booking, packed cell volume (PCV), pregnant women Dans les pays en développement comme le Nigeria, l'anémie pendant la grossesse est considérée comme l'une des complications les plus courantes de la grossesse, responsable d'un niveau important de morbidité et de mortalité maternelles. Le but de cette étude était de déterminer la prévalence de l'anémie pendant la grossesse chez les femmes fréquentant la clinique prénatale (ANC) de réservation àl'hôpital universitaire d'État de Benue (BSUTH), centre-nord, Nigéria. Une étude descriptive transversale a été menée de mai 2019 àjanvier 2020 sur 299 femmes. Un questionnaire structuré administré par un intervieweur a été utilisé pour obtenir des informations socio-démographiques, cliniques et nutritionnelles auprès des femmes enceintes fréquentant la clinique qui ont consenti àparticiper àl'étude. Les niveaux d'hématocrite ont été stratifiés selon la classification de l'Organisation mondiale de la santé (OMS) comme suit : < 7 mg/dL - sévère, 7-8,99 mg/dL - modéré, 9 - 10,99 mg/dL - anémie légère et [??] 11 mg/dL - nonanémique. Les données ont été analysées àl'aide de SPSS version 25.0. Le test du chi carré a été effectué pour déterminer les relations. Un modèle de régression logistique multivariée a été utilisé pour identifier les facteurs de risque d'anémie chez les femmes enceintes. Une valeur de p < 0,05 et un rapport de cotes avec un intervalle de confiance à95% ont été utilisés pour évaluer l'association. L'âge moyen des répondants était de 29,9 ans, allant de 18 à40 ans. Cent vingt-trois (41,1%) femmes étaient anémiques (hémoglobine [Hb] < 11,0 g/dL). La majorité (95,1%) de ces patients anémiques étaient légèrement anémiques, tandis que 4,9% étaient modérément anémiques. Il n'y a eu aucun cas d'anémie sévère (Hb < 7,0 g/dL). La prévalence de l'anémie était significativement plus élevée chez les personnes âgées de 20 à24 ans et chez celles ayant un faible niveau d'éducation (P < 0,05). L'âge gestationnel de la patiente, le nombre de fausses couches et l'intervalle entre les naissances n'avaient pas de relation significative avec la concentration d'hémoglobine chez les femmes enceintes de cette étude (P > 0,05). Cependant, la parité, les caractéristiques cliniques telles que la fièvre et les pratiques telles que l'utilisation d'hématiniques et la non-consommation de viande, de volaille et de poisson étaient significativement liées àl'anémie (P < 0,05). Les femmes enceintes qui ne prenaient pas d'hématiniques avaient 5,8 fois plus de risque de développer une anémie (OR=5,8, IC95% [2,3, 14,5]) tandis que les femmes enceintes qui ne mangeaient pas de viande, de volaille ou de poisson avaient 9 fois plus de risque de devenir anémiques que femmes enceintes qui mangeaient (OR=9,0, IC95%[1,0, 79,5]). La prévalence de l'anémie pendant la grossesse est élevée chez les femmes qui fréquentent la clinique prénatale de BSUTH, dans le centre-nord du Nigéria, et nécessite une intervention spécifique qui s'attaque aux facteurs de risque identifiés. (Afr JReprodHealth 2022; 26[12s]: 161-168). Mots-clés: Anémie, consultation prénatale, réservation, hématocrite (PCV), femmes enceintes, Introduction Anaemia is a global public health challenge. It is the reduction in the haemoglobin concentration in the peripheral blood, below that adequate for age, sex and place of residence [...]

2023 DEC 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

A Texas woman had to go before a court for permission to abort her fetus with a fatal abnormality. State Attorney General Ken Paxton threatened to prosecute the woman's healthcare [...]

2023 OCT 7 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Obesity, Fitness and Wellness have been published. According [...]

A person is considered obese when their body mass index (BMI) is 30 or higher. For people who become pregnant, being obese can increase the risk of many health conditions [...]